Igor Rybkin

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Case report · Cancer Discovery · 2020 · 1,061 citations

Acquired Resistance to KRASG12C Inhibition in Cancer

New England Journal of Medicine · 2021 · 1,038 citations